Recombinant polymerases with increased phototolerance

• US RE47,177 E1
• Filed: 01/24/2018
• Issued: 12/25/2018
• Est. Priority Date: 02/01/2012
• Status: Active Grant

• Current Assignee: Pacific Bioscience of California Incorporated (L'Oreal SA)
• Original Assignee: Pacific Bioscience of California Incorporated (L'Oreal SA)
• Inventors: Kamtekar, Satwik, Bibillo, Arek, Bjornson, Keith, Christians, Fred, Cutcliffe, Colleen, Hanes, Jeremiah, Jia, Lei, Lee, Walter, Miller, Erik, Patel, Pranav
• Primary Examiner(s): Campell, Bruce R
• Application Number:
  US15/879,220
• Time in Patent Office: 335 Days
• CPC Class Codes: C12N 9/1252 DNA-directed DNA polymerase (2.7.7.7), i.e. DNA replicase
• CPC Class Codes: C12P 19/34 Polynucleotides, e.g. nucleic acids, oligoribonucleotides
• CPC Class Codes: C12Q 1/6869 Methods for sequencing
• CPC Class Codes: C12Y 207/07007 DNA-directed DNA polymerase (2.7.7.7), i.e. DNA replicase
• CPC Class Codes: Y02P 20/52 using catalysts, e.g. selective catalysts

Abstract

Provided are compositions comprising recombinant DNA polymerases that include amino acid substitutions, insertions, deletions, and/or exogenous features that confer modified properties upon the polymerase for enhanced single molecule sequencing. Such properties include increased resistance to photodamage, and can also include enhanced metal ion coordination, reduced exonuclease activity, reduced reaction rates at one or more steps of the polymerase kinetic cycle, decreased branching fraction, altered cofactor selectivity, increased yield, increased thermostability, increased accuracy, increased speed, increased readlength, and the like. Also provided are nucleic acids which encode the polymerases with the aforementioned phenotypes, as well as methods of using such polymerases to make a DNA or to sequence a DNA template.

Claims

1. A composition comprising Φ

29-type (phi29-type) recombinant DNA polymerase, which recombinant polymerase comprises an amino acid sequence that is at least 80% identical to SEQ ID NO;

1, and which recombinant polymerase comprises one or more mutation selected from the group consisting of an amino acid substitution at position K131, an amino acid substitution at position K132, a K135Q substitution, a K135S substitution, an H149D substitution, a Q183F substitution, a G197D substitution, a G197E substitution, an 1201E I201E substitution, a K206E substitution, and an A437N substitution, and a D510S substitution, wherein identification of positions is relative to SEQ ID NO;

1, and wherein said polymerase exhibits polymerase activity.

2. The composition of claim 1, wherein the recombinant polymerase comprises a K131E substitution or a K131Q substitution, wherein identification of positions is relative to SEQ ID NO:

1.

3. The composition of claim 1, wherein the recombinant polymerase comprises one or more mutation or combination of mutations selected from the group consisting of an amino acid substitution at position 253, an amino acid substitution at position 375, an amino acid substitution at position 484, an amino acid substitution at position 512, an amino acid substitution at position 510, an amino acid substitution at position 148, an amino acid substitution at position 224, an amino acid substitution at position 239, an amino acid substitution at position 250, an amino acid substitution at position 437, an amino acid substitution at position 235, an amino acid substitution at position 515, an amino acid substitution at position 141, an amino acid substitution at position 142, an amino acid substitution at position 504, an amino acid substitution at position 508, an amino acid substitution at position 513, an amino acid substitution at position 523, an amino acid substitution at position 536, an amino acid substitution at position 539, an amino acid substitution at position 205, an amino acid substitution at position 472, an amino acid substitution at position 437 and an amino acid substitution at position 253, an amino acid substitution at position 508 and an amino acid substitution at position 510, an A437G substitution and an L253H substitution, an A437G substitution and an L253C substitution, a V250A substitution and an L253H substitution, an A437G substitution, a D235E substitution, an E515Q substitution, an E515P substitution, an E515K substitution, a V250A substitution, a V250I substitution, a Y148I substitution, a Y224K substitution, an E239G substitution, a V141K substitution, an L142K substitution, an E508K substitution, an E508K substitution and a D510S substitution, a K536Q substitution, a K539Q substitution, a K205E substitution, a K205D substitution, a K205A substitution, a K472A substitution, an E375Y substitution, a K512Y substitution, an A484E substitution, an L253A substitution, an L253C substitution, an L253S substitution, an L253H substitution, and a D510K substitution, wherein identification of positions is relative to SEQ ID NO:

1.

4. The composition of claim 1, wherein the recombinant polymerase comprises E375Y, A484E, and K512Y substitutions, wherein identification of positions is relative to SEQ ID NO:

1.

5. The composition of claim 1, wherein the recombinant polymerase comprises one of the following combinations of mutations a) through q) selected from the group consisting of:

a) K131E, Y148I, Y224K, E239G, V250I, L253A, E375Y, A437G, A484E, D510K, K512Y, and E515Q;

b) K135Q, Y148I, Y224K, E239G, V250I, L253A, E375Y, A437G, A484E, D510K, K512Y, and E515Q;

c) K131E, Y148I, Y224K, D235E, E239G, V250A, L253H, E375Y, A437G, A484E, D510K, K512Y, and E515Q;

d) Y148I, Y224K, E239G, L253S, E375Y, A437G, A484E, D510K, K512Y, and E515Q;

e) Y148I, Q183F, D235E, E239G, L253H, E375Y, A437G, A484E, D510K, K512Y, and E515Q;

f) Y148I, Y224K, E239G, V250I, L253H, E375Y, A437G, A484E, D510K, and K512Y;

g) Y148I, Y224K, E239G, V250I, L253A, E375Y, A437G, A484E, D510K, K512Y, and E515Q;

h) K131E, Y148I, Y224K, D235E, E239G, L253H, E375Y, A437G, A484E, D510K, K512Y, and E515Q;

i) Y148I, Y224K, D235E, E239G, L253H, E375Y, A437G, A484E, D510K, K512Y, and E515Q;

j) Y148I, Y224K, E239G, V250I, L253A, E375Y, A437G, A484E, D510K, and K512Y;

k) Y148I, Y224K, E239G, V250I, L253A, E375Y, A437G, A484E, D510K, and K512Y;

l) K131E, Y148I, Y224K, E239G, V250I, L253A, E375Y, A484E, D510K, and K512Y;

m) K135Q, Y148I, Y224K, E239G, V250I, L253A, E375Y, A484E, D510K, and K512Y;

n) Y148I, Y224K, E239G, L253H, E375Y, A437G, A484E, D510K, and K512Y;

o) K131E, K135Q, V141K, L142K, Y148I, Y224K, E239G, V250I, L253A, E375Y, A437G, A484E, E508K, D510K, K512Y, E515Q, and K536Q;

p) K131E, Y148I, Y224K, E239G, V250I, L253A, E375Y, A437G, A484E, E508K, D510K, K512Y, and E515Q; and

q) K131Q, Y148I, Y224K, E239G, V250I, L253A, E375Y, A484E, D510K, and K512Y;

wherein identification of positions is relative to SEQ ID NO;

1.

6. The composition of claim 5, wherein the recombinant polymerase comprises an amino acid sequence that is at least 90% identical to SEQ ID NO:

1.

7. The composition of claim 5, wherein the C-terminal region of the recombinant polymerase comprises a His 10 tag.

8. The composition of claim 1, where the recombinant polymerase comprises an amino acid sequence that is at least 90% identical to SEQ ID NO:

1.

9. The composition of claim 1, wherein the recombinant polymerase comprises one or more exogenous features at the C-terminal and/or N-terminal region of the polymerase.

10. The composition of claim 9, wherein the recombinant polymerase comprises a biotin ligase recognition sequence and a polyhistidine tag.

11. The composition of claim 1, comprising a phosphate-labeled nucleotide analog.

12. The composition of claim 11, wherein the nucleotide analog comprises a fluorophore.

13. The composition of claim 1, comprising a phosphate-labeled nucleotide analog and a DNA template, wherein the recombinant polymerase incorporates the nucleotide analog into a copy nucleic acid in response to the DNA template.

14. The composition of claim 1, wherein the composition is present in a DNA sequencing system.

15. The composition of claim 14, wherein the sequencing system comprises a zero-mode waveguide.

16. The composition of claim 15, wherein the recombinant polymerase is immobilized on a surface of the zero-mode waveguide in an active form.

17. The composition of claim 1, wherein the recombinant polymerase comprises an amino acid sequence selected from the group consisting of SEQ ID NOs:

27-29, SEQ ID NO;

31, SEQ ID NO;

34, SEQ ID NO;

38, SEQ ID NO;

39, and SEQ ID NOs;

43-46 NOs;

44-46.

18. A method of sequencing a DNA template, the method comprising:

a) providing a reaction mixture comprising;

the DNA template,

a replication initiating moiety that complexes with or is integral to the template,

the recombinant polymerase of claim 1, wherein the polymerase is capable of replicating at least a portion of the template using the moiety in a template-dependent polymerization reaction, and

one or more nucleotides and/or nucleotide analogs;

b) subjecting the reaction mixture to a polymerization reaction in which the modified recombinant polymerase replicates at least a portion of the template in a template-dependent manner, whereby the one or more nucleotides and/or nucleotide analogs are incorporated into the resulting DNA; and

c) identifying a time sequence of incorporation of the one or more nucleotides and/or nucleotide analogs into the resulting DNA.

19. The method of claim 18, wherein the subjecting and identifying steps are performed in a zero mode waveguide.

20. A method of making a DNA, the method comprising:

(a) providing a reaction mixture comprising;

a template,

a replication initiating moiety that complexes with or is integral to the template,

the recombinant polymerase of claim 1, which polymerase is capable of replicating at least a portion of the template using the moiety in a template-dependent polymerase reaction, and

one or more nucleotides and/or nucleotide analogs; and

(b) reacting the mixture such that the polymerase replicates at least a portion of the template in a template-dependent manner, whereby the one or more nucleotides and/or nucleotide analogs are incorporated into the resulting DNA.

21. The method of claim 20, wherein the mixture is reacted in a zero mode waveguide.

22. The method of claim 20, the method comprising detecting incorporation of at least one of the nucleotides and/or nucleotide analogs.